News Amgen Inc.

Equities

AMGN

US0311621009

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-17 pm EDT			Pre-market 08:28:38 am
335.7 ^USD	+0.76%		335.7	+0.00%

Jul. 12	Health Care Up as Momentum Builds -- Health Care Roundup	DJ
Jul. 12	UBS Raises Price Target on Amgen to $337 From $307, Maintains Neutral Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amgen Hasn't Resolved Questions On AI Medical Invention Patents	Jul. 17	AQ
Health Care Up as Momentum Builds -- Health Care Roundup	Jul. 12	DJ
Amgen : Statement on IRS Notice Related to Horizon Acquisition	Jul. 12	PU
UBS Raises Price Target on Amgen to $337 From $307, Maintains Neutral Rating	Jul. 12	MT
Morgan Stanley Adjusts Price Target on Amgen to $303 From $310	Jul. 11	MT
DexCom, Inc. : A Must-Have Tool for Diabetes Care	Jul. 10
Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints	Jul. 02	MT
Amgen Inc.(NasdaqGS:AMGN) added to Russell 1000 Dynamic Index	Jun. 30	CI
Argus Raises Amgen's Price Target to $340 From $300	Jun. 27	MT
Amgen CEO Bob Bradway’s Advice to Amgen’s Summer Interns: Don’t Hold Back	Jun. 27	PU
Out with AI, in with defensive stocks	Jun. 25
US FDA approves Roche's drug for a chronic blood disorder	Jun. 21	RE
Amgen : Bringing Cardiovascular Care to the Heart of Communities	Jun. 20	PU
Amgen : Continues to Propel BiTE® Technology Innovation	Jun. 20	PU
Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto	Jun. 14	DJ
Amgen : Continues to Propel BiTE® Technology Innovation	Jun. 14	PU
Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer	Jun. 14	MT
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE	Jun. 14	PR
Amgen Inc. Announces U.S. Food and Drug Administration Approves Blincyto	Jun. 14	CI
Sector Update: Health Care Stocks Softer Friday Afternoon	Jun. 14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Amgen Inc.

Equities

AMGN

US0311621009

Summary

Filters